Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Veracyte Inc (VCYT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Veracyte Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced new data demonstrating that its next-generation Percepta(R) Genomic Sequencing Classifier (GSC)...

VCYT : 24.18 (-0.86%)
Relatively Good Performance Detected in Shares of Biomarin Pharmac in the Biotechnology Industry (BMRN , VCYT , ADMS , RTRX , EXAS )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

VCYT : 24.18 (-0.86%)
ADMS : 5.46 (-4.71%)
BMRN : 86.66 (-2.31%)
Veracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced that it has named Sangeeta Bhorade, M.D., medical director of pulmonology. In this role, Dr. Bhorade...

VCYT : 24.18 (-0.86%)
Veracyte to Present at the UBS Global Healthcare Conference

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to present at the...

VCYT : 24.18 (-0.86%)
Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Veracyte, Inc. (Nasdaq: VCYT) announced today the closing of its public offering of 6,325,000 shares of common stock, including 825,000 shares sold upon full exercise of the underwriters'...

VCYT : 24.18 (-0.86%)
MS : 43.87 (-0.02%)
Uptrend Call Working As Veracyte Inc Stock Rises 71.6% (VCYT)

SmarTrend identified an Uptrend for Veracyte Inc (NASDAQ:VCYT) on January 4th, 2019 at $14.02. In approximately 4 months, Veracyte Inc has returned 71.61% as of today's recent price of $24.06.

VCYT : 24.18 (-0.86%)
Veracyte Announces Pricing of Public Offering of 5,500,000 Shares of Common Stock

Veracyte, Inc. (Nasdaq: VCYT) (the "Company") today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a public offering price of $23.25 per...

VCYT : 24.18 (-0.86%)
Relatively Good Performance Detected in Shares of Veracyte Inc in the Biotechnology Industry (VCYT , NBIX , LXRX , INCY , VRTX )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

VCYT : 24.18 (-0.86%)
LXRX : 5.82 (-6.13%)
NBIX : 76.68 (-2.97%)
Veracyte Announces Proposed Public Offering of Common Stock

Veracyte, Inc. (Nasdaq: VCYT) ("the Company") today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. All of the shares are being offered...

VCYT : 24.18 (-0.86%)
Veracyte: 1Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Veracyte Inc. (VCYT) on Tuesday reported a loss of $1.9 million in its first quarter.

VCYT : 24.18 (-0.86%)
Veracyte, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 30, 2019 / Veracyte, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on April 30, 2019 at 5:00 PM Eastern Time....

VCYT : 24.18 (-0.86%)
Uptrend Call Working As Veracyte Inc Stock Rises 64.6% (VCYT)

SmarTrend identified an Uptrend for Veracyte Inc (NASDAQ:VCYT) on January 4th, 2019 at $14.02. In approximately 4 months, Veracyte Inc has returned 64.55% as of today's recent price of $23.07.

VCYT : 24.18 (-0.86%)
Will Veracyte (VCYT) Report Negative Earnings Next Week? What You Should Know

Veracyte (VCYT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VCYT : 24.18 (-0.86%)
Veracyte Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York State

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, announced today that it has received regulatory authorization from the New York State Department of Health to...

VCYT : 24.18 (-0.86%)
Veracyte Names Alfred Bowie, Jr., Ph.D. as Vice President, Corporate and Business Development

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced that it has named Alfred "Freddie" Bowie, Jr., Ph.D., as vice president, corporate and business...

VCYT : 24.18 (-0.86%)
Veracyte Announces Publication Highlighting Afirma GSC's Ability to Rule Out Cancer in Challenging Thyroid Nodule Subtype

Veracyte, Inc. announced today that a new study published online in BMC Systems Biology showcases the development of the Afirma(R) Genomic Sequencing Classifier (GSC) and its ability...

VCYT : 24.18 (-0.86%)
Relatively Good Performance Detected in Shares of Veracyte Inc in the Biotechnology Industry (VCYT , LXRX , BCRX , DVAX , KPTI )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

VCYT : 24.18 (-0.86%)
LXRX : 5.82 (-6.13%)
BCRX : 7.39 (+0.82%)
Veracyte to Release First Quarter 2019 Financial Results on April 30, 2019

Veracyte, Inc. (Nasdaq: VCYT) today announced that it will release its financial results for the first quarter 2019 after the close of market on Tuesday, April 30, 2019. Company management...

VCYT : 24.18 (-0.86%)
73.0% Return Seen to Date on SmarTrend Veracyte Inc Call (VCYT)

SmarTrend identified an Uptrend for Veracyte Inc (NASDAQ:VCYT) on January 4th, 2019 at $14.02. In approximately 3 months, Veracyte Inc has returned 73.04% as of today's recent price of $24.26.

VCYT : 24.18 (-0.86%)
Veracyte Announces Data Published in The Lancet Respiratory Medicine Demonstrate that the Envisia Genomic Classifier Improves Diagnosis of IPF

Veracyte, Inc. announced that data published online today in The Lancet Respiratory Medicine suggest that use of the company's Envisia Genomic Classifier improves diagnosis for patients...

VCYT : 24.18 (-0.86%)

Van Meerten Stock Picks

Aaon - Pick of the Day
My Stock Pick of the Day is the HVAC company AAON (AAON).
AAON +0.83
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar